跳至主要内容
临床试验/EUCTR2010-023070-40-ES
EUCTR2010-023070-40-ES进行中(未招募)不适用

An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 during Surgical Procedures in Patients with Haemophilia B - paradigm?3

ovo Nordisk A/S0 个研究点目标入组 16 人开始时间: 2012年11月29日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • ? Patients with haemophilia B, aged 13-70 years and with a FIX activity of ?2%.
  • ? Male patients with moderately severe or severe congenital haemophilia B with a FIX activity ?2% according to medical records
  • ? History of at least 150 exposure days to other FIX products
  • ? Scheduled major surgery
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 2
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 6
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 2

排除标准

  • ? Known history of FIX inhibitors based on existing medical records, laboratory report reviews and patient and LAR interviews
  • ? Current FIX inhibitors ?0.6 BU (central laboratory)
  • ? Previous arterial thrombotic events (e.g. myocardial infarction and intracranial thrombosis) or previous deep venous thrombosis or pulmonary embolism (as defined by available medical records)
  • ? ALT >3 times the upper limit of normal reference ranges at screening (central laboratory)
  • ? Immune modulating or chemotherapeutic medication

研究者

相似试验

进行中(未招募)
不适用
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 during Surgical Procedures in Patients with Haemophilia BHaemophilia BMedDRA version: 15.1Level: LLTClassification code 10018939Term: Haemophilia B (Factor IX)System Organ Class: 100000004850
EUCTR2010-023070-40-ATovo Nordisk A/S16
撤回
3 期
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 during Surgical Procedures in Patients with Haemophilia Bblood clotting disorderHaemophilia B10064477
NL-OMON36798ovo Nordisk2
进行中(未招募)
不适用
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 during Surgical Procedures in Patients with Haemophilia B - Paradigm 3
EUCTR2010-023070-40-ITOVO NORDISK16
进行中(未招募)
不适用
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 during Surgical Procedures in Patients with Haemophilia B - paradigm™3
EUCTR2010-023070-40-NLovo Nordisk A/S16
进行中(未招募)
不适用
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 during Surgical Procedures in Patients with Haemophilia B - paradigm™3Haemophilia BMedDRA version: 14.1Level: LLTClassification code 10018939Term: Haemophilia B (Factor IX)System Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2010-023070-40-GBovo Nordisk A/S16